InsiderClue
Insiders · Profile

Hacksell Uli

Director at Avalo Therapeutics · CEO at ACADIA PHARMACEUTICALS. Filing since 16 May 2007. CIK 0001291962

AVTX Avalo Therapeutics, Inc. Director · 2 trades ACAD ACADIA PHARMACEUTICALS INC CEO · 22 trades
Company
Date
Role
Action
Shares
Amount
Of holding
AVTX Avalo Therapeutics, Inc.
9 Jun 2017
Director
Bought
10,000
$4.20K
100%
AVTX Avalo Therapeutics, Inc.
10 Dec 2016
Director
Bought
10,000
$10.70K
opened
ACAD ACADIA PHARMACEUTICALS INC
17 Feb 2015
CEO
Sold, plan not stated
30,000
$1.03M
20.6%
ACAD ACADIA PHARMACEUTICALS INC
14 Jan 2015
CEO
Sold, plan not stated
30,000
$1.02M
20.6%
ACAD ACADIA PHARMACEUTICALS INC
15 Dec 2014
CEO
Sold, plan not stated
30,000
$929.92K
20.6%
ACAD ACADIA PHARMACEUTICALS INC
24 Nov 2014
CEO
Sold, plan not stated
30,000
$878.40K
20.6%
ACAD ACADIA PHARMACEUTICALS INC
8 Oct 2014
CEO
Sold, plan not stated
30,000
$724.53K
20.6%
ACAD ACADIA PHARMACEUTICALS INC
10 Sep 2014
CEO
Sold, plan not stated
30,000
$820.82K
20.6%
ACAD ACADIA PHARMACEUTICALS INC
15 Aug 2014
CEO
Sold, plan not stated
15,000
$343.37K
11.5%
ACAD ACADIA PHARMACEUTICALS INC
14 Jul 2014
CEO
Sold, plan not stated
20,000
$444.37K
14.8%
ACAD ACADIA PHARMACEUTICALS INC
16 Jun 2014
CEO
Sold, plan not stated
20,000
$462.00K
14.8%
ACAD ACADIA PHARMACEUTICALS INC
15 Apr 2014
CEO
Sold, plan not stated
25,000
$443.84K
17.8%
ACAD ACADIA PHARMACEUTICALS INC
18 Feb 2014
CEO
Sold, plan not stated
25,000
$603.53K
17.8%
ACAD ACADIA PHARMACEUTICALS INC
15 Jan 2014
CEO
Sold, plan not stated
25,000
$600.29K
17.8%
ACAD ACADIA PHARMACEUTICALS INC
2 Dec 2013
CEO
Sold, plan not stated
15,000
$351.81K
12.1%
ACAD ACADIA PHARMACEUTICALS INC
1 Nov 2013
CEO
Sold, plan not stated
15,000
$348.64K
12.1%
ACAD ACADIA PHARMACEUTICALS INC
13 Aug 2013
CEO
Sold, plan not stated
52,771
$1.06M
32.6%
ACAD ACADIA PHARMACEUTICALS INC
2 May 2013
CEO
Sold, plan not stated
20,449
$252.40K
15.8%
ACAD ACADIA PHARMACEUTICALS INC
1 May 2013
CEO
Sold, plan not stated
19,551
$248.52K
15.2%
ACAD ACADIA PHARMACEUTICALS INC
16 Apr 2013
CEO
Sold, plan not stated
16,729
$206.05K
13.3%
ACAD ACADIA PHARMACEUTICALS INC
1 Apr 2013
CEO
Sold, plan not stated
40,000
$307.04K
26.8%
ACAD ACADIA PHARMACEUTICALS INC
6 Dec 2007
CEO
Sold, plan not stated
14,000
$175.51K
18.9%
ACAD ACADIA PHARMACEUTICALS INC
4 Sep 2007
CEO
Sold, plan not stated
14,000
$208.91K
15.9%
ACAD ACADIA PHARMACEUTICALS INC
16 May 2007
CEO
Sold, plan not stated
35,000
$451.24K
28.5%
24 decisions on file.